SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

Madrigal Pharmaceuticals Q1 EPS $(2.340) Down From $(0.980) YoY

Madrigal Pharmaceuticals (NASDAQ:MDGL) reported quarterly losses of $(2.340) per share. This is a 138.78 percent decrease over losses of $(0.980) per share from the same period last year.

Benzinga · 05/07/2020 10:51

Madrigal Pharmaceuticals (NASDAQ:MDGL) reported quarterly losses of $(2.340) per share. This is a 138.78 percent decrease over losses of $(0.980) per share from the same period last year.